Depo-Provera Litigation Group

Depo-Provera is intended for use in providing contraception and/or regulation of irregular menstrual cycles. Unfortunately, Depo-Provera is now known to cause meningioma, a common type of primary brain tumor. The Litigation Group provides critical information and materials for AAJ members to organize, educate, and coordinate as they navigate the complexities of this litigation.

Group History:

The Depo-Provera Litigation Group was formed in the Fall of 2024.

Membership:
The Depo-Provera Litigation Group is limited to Regular, Sustaining, Life, and President’s Club Members

Dues:
The Depo-Provera Litigation Group is complimentary to members of the AAJ Pharmaceutical and Medical Device Section who can agree to the terms and conditions of membership in the Litigation Group’s Affidavit.

Litigation Group Cochairs:
Chelsea Green | Levin Papantonio, Pensacola, FL
Brendan McDonough | Weitz & Luxenberg, PC, New York, NY
Doug Kreis | Aylstock Witkin Kreis & Overholtz, PLLC, Pensacola, FL
Shayna Slater | Anapol Weiss, Philadelphia, PA